HomeInsightsPE

Aarti Pharmalabs Ltd PE Ratio

Aarti Pharmalabs Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

1.6 K

stocks traded

Last Updated time: 19 Sep 10:27 AM

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

PE

26.5

Last updated: 19 Sep 10:27 AM

Key Highlights

  • The P/E Ratio of Aarti Pharmalabs Ltd is 26.5 as of 19 Sep 10:27 AM.
  • The P/E Ratio of Aarti Pharmalabs Ltd changed from 12.9 on March 2021 to 18.2 on March 2024 . This represents a CAGR of 18.78% over 2 years. .
  • The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 646.15 as of 19 Sep 10:20.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.2. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.8. In 2024.

Historical P/E Ratio of Aarti Pharmalabs Ltd

No data available

Company Fundamentals for Aarti Pharmalabs Ltd

No data available

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

PRICE

646.15

-11.35 (-1.73%)

stock direction

Last updated: 19 Sep 10:20

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Aarti Pharmalabs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 2024657.5
17 Sep 2024663.7
16 Sep 2024676.05
13 Sep 2024658.5
12 Sep 2024668.8
11 Sep 2024673.35
10 Sep 2024679.2
09 Sep 2024678.35
06 Sep 2024695.9
05 Sep 2024690.8

SWOT Analysis Of Aarti Pharmalabs Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aarti Pharmalabs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aarti Pharmalabs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Aarti Pharmalabs Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Revenue of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Aarti Pharmalabs Ltd

No data available

* All values are in %

About Aarti Pharmalabs Ltd

  • Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019.
  • The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India.
  • In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.
  • It expanded block for CSD, Vapi and API, Tarapur units in 2022.
  • The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021.

Aarti Pharmalabs Ltd News Hub

News

Aarti Pharmalabs to convene board meeting

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 5 August ...

Read more

30 Jul 202411:17

News

Aarti Pharmalabs schedules AGM

Aarti Pharmalabs announced that the 91th Annual General Meeting (AGM) of the company will ...

Read more

17 Jul 202409:30

News

CRISIL reaffirms ratings of Aarti Pharmalabs with 'positive' outlook

CRISIL stated that the ratings continue to reflect the established market position in the ...

Read more

27 Jun 202413:54

News

Aarti Pharmalabs Ltd leads losers in 'A' group

Colgate-Palmolive (India) Ltd, Jyothy Labs Ltd, Archean Chemical Industries Ltd and Aarti ...

Read more

15 May 202415:00

News

Aarti Pharmalabs jumps after Q4 PAT climbs 52% YoY to Rs 65 cr

Revenue from operations increased 4.27% YoY to Rs 505.77 crore in Q4 FY24. Profit before t...

Read more

14 May 202409:43

News

Board of Aarti Pharmalabs recommends Final Dividend

Aarti Pharmalabs announced that the Board of Directors of the Company at its meeting held ...

Read more

13 May 202417:30

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Aarti Pharmalabs Ltd

What is the current PE Ratio of Aarti Pharmalabs Ltd?

The Current PE Ratio of Aarti Pharmalabs Ltd is 26.45 as on 19 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.2 as on 19 Sep 2024.

What was the PE Ratio of Aarti Pharmalabs Ltd last year?

The PE Ratio of Aarti Pharmalabs Ltd was 12.86 last year, now the PE ratio is 26.45, showing a year-on-year growth of 105.7%.

What does the PE Ratio of Aarti Pharmalabs Ltd indicate about its stock?

The PE Ratio of Aarti Pharmalabs Ltd is 26.45. This ratio indicates that investors are willing to pay 26.45 times the earnings per share for each share of Aarti Pharmalabs Ltd.

What is the PE Ratio Growth of Aarti Pharmalabs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Aarti Pharmalabs Ltd grew by 105.7% whereas, the EPS ratio grew by -15.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*